UAE Upstream Bioprocessing Market Size & Outlook
UAE upstream bioprocessing market, 2018-2030 (US$M)
Related Markets
UAE upstream bioprocessing market highlights
- The UAE upstream bioprocessing market generated a revenue of USD 131.0 million in 2023 and is expected to reach USD 331.0 million by 2030.
- The UAE market is expected to grow at a CAGR of 14.2% from 2024 to 2030.
- In terms of segment, bioreactors/fermenters was the largest revenue generating product in 2023.
- Cell Culture Products is the most lucrative product segment registering the fastest growth during the forecast period.
Upstream bioprocessing market data book summary
| Market revenue in 2023 | USD 131.0 million |
| Market revenue in 2030 | USD 331.0 million |
| Growth rate | 14.2% (CAGR from 2023 to 2030) |
| Largest segment | Bioreactors/fermenters |
| Fastest growing segment | Cell Culture Products |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Bioreactors/Fermenters, Cell Culture Products, Filters, Bioreactors Accessories, Bags & Containers |
| Key market players worldwide | Thermo Fisher Scientific Inc, Merck KGaA, Corning Inc, Sartorius AG, Eppendorf, Danaher Corp, Boehringer Ingelheim, Getinge AB Class B, Lonza Group Ltd, Avantor Inc, Repligen Corp, Entegris Inc, PBS Biotech, Meissner, Kuhner Shaker |
Other key industry trends
- In terms of revenue, UAE accounted for 0.5% of the global upstream bioprocessing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa upstream bioprocessing market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 331.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Upstream Bioprocessing Market Scope
Upstream Bioprocessing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
UAE upstream bioprocessing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to upstream bioprocessing market will help companies and investors design strategic landscapes.
Bioreactors/fermenters was the largest segment with a revenue share of 33.05% in 2023. Horizon Databook has segmented the UAE upstream bioprocessing market based on bioreactors/fermenters, cell culture products, filters, bioreactors accessories, bags & containers covering the revenue growth of each sub-segment from 2018 to 2030.
The broadening applications of biopharmaceutical products in the UAE is expected to boost the adoption of these products, consequently increasing the demand for upstream bioprocessing products in the near future. Strategic initiatives adopted by companies to commercialize biopharmaceutical products in this region support market growth.
For instance, in January 2020, Mubadala Investment Company financed USD 4.22 million for Zihipp Limited, a UK-based biopharmaceutical company, to deliver treatments for obesity and diabetes. In November 2019, Yas Holding, an Abu Dhabi-based investment company, acquired a 2.5% business stake in Alvotech, an Iceland-based biopharmaceutical company.
Reasons to subscribe to UAE upstream bioprocessing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of UAE upstream bioprocessing market databook
-
Our clientele includes a mix of upstream bioprocessing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the UAE upstream bioprocessing market , including forecasts for subscribers. This country databook contains high-level insights into UAE upstream bioprocessing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
UAE upstream bioprocessing market size, by product, 2018-2030 (US$M)
UAE Upstream Bioprocessing Market Outlook Share, 2023 & 2030 (US$M)
Related industry reports
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
